Priority Date: 25.01.11 (US 201161436077P)

BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

  • Application ID: EP12739376
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 1879
Headquarter in Torino and 7 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 222 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.01.2011 - Priority Date (US 201161436077P)
  • 02.08.2012 - Publication A2 (WO2012103059)
  • 04.12.2013 - Publication A2 (EP2668180)